Verily

HbA1c values also declined across a sample of program participants, many of whom said they were unfamiliar with the diabetes management tools prior to enrollment.

A newly published notice from the FDA suggests a new capability for the Alphabet subsidiary's clinical research wearable.

Dexcom CEO Kevin Sayer has seen the company through some boom years, including growth that has outpaced the company's manufacturing capabilities. But they've learned lessons and are pressing on with a new, smaller sensor in 2021.

Also: Bardy Diagnostics names Ed Vertatschisch as next COO; Sapphire Digital names Kyle Raffaniello as permanent CEO. 

Also: Ooda Health's CEO shuffle; CMMI's new director.

The industry is better off viewing the the floundering deals between Onduo and Sanofi, Proteus and Otsuka, and Pear and Sandoz as a learning opportunity.

From its acquisition of Fitbit to Project Nightingale, 2019 has been eventful for Alphabet and its subsidiaries. 

Pharma companies also continued to explore the promises of digital therapeutics. 

Women make up 12.2 percent of digital health VC partners, but many in the industry are discussing the importance of diverse viewpoints. 

Google also announced that it is shutting down the Google Fit website on March 19.